Relevium Announces 2018 AGM Results

MONTREAL, QUEBEC--(Marketwired - Feb. 16, 2018) - Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce the positive results from its annual and special meeting held on February 15, 2018 in Montréal, Canada (the "AGM").

Election of Directors

The shareholders supported the appointment of the Board and the resolutions proposed. The number of directors was fixed at five and the shareholders elected management's nominees for directors.

In addition to the incumbent board members that include Mr. Andre Godin, Executive Vice-President and CFO of IntelGenx; Mr. Michel Timperio, Head of Strategic Development at Neptune Technologies and Bioressources and President, Neptune Wellness Solution Cannabis Division; Mr. Pierre Bertrand, Vice-President of the Optical Dispensing Solutions division of Essilor USA and Dr. Tina Sampalis, President of Vanguard Strategic Consulting and Founder/President of the Agoo Children's Health & Wellness Center, the shareholders also elected Mr. Aurelio Useche, President and CEO of Relevium.

The Board of Directors is now comprised of four independent directors and one executive director. As the Company's President & CEO, Mr. Useche's election to the Board of Directors allows for a stronger link between the board and management into developing and evolving the Company's strategy.

Aurelio Useche, President and CEO of Relevium stated: "We are very pleased to have the strong support of our shareholders. We believe that Relevium has put together a Board of Directors with the right combination of public company experience and complimentary business acumen in the areas of corporate finance, nutraceuticals, pharmaceuticals and wellness which, alongside management, should provide the ideal conditions for the successful execution of the Company's overall strategy."

The Company would like to thank outgoing directors Ms. Kristine Dorward and Dr. Ted Zablotsky for their valuable contributions and commitment during their tenure at Relevium.

Appointment and Remuneration of Auditor

Shareholders also appointed Ernst & Young LLP, Chartered Accountants as the auditor of the Company and the Directors were authorized to fix their remuneration.

Amendment to Stock Option Plan

The shareholders also approved the amendment to the Company's 2012 stock option plan made on December 22, 2017 (see Press Release of December 22, 2017) in which the maximum number of common shares of the Company issuable upon the exercise of stock options increased from 3,838,847 to 6,983,684, allowing the Company's stock option plan to remain as a less than 10% fixed plan.